Raymond James Financial Inc. bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).

This was the stock's second consecutive day of losses.

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

The stock's fall snapped a four-day winning streak.

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the Barclays 27th Annual Global Healthcare Conference. “That is a huge tailwind ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zimmer Biomet's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4 ...